WebJul 1, 2024 · On June 29, 2024, Cytiva announced that it has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Through the acquisition, Cytiva will use Intermountain’s manufacturing site in Logan, Utah to rapidly boost its liquid cell culture production by millions of liters. WebI am thrilled to announce that Cytiva has acquired Intermountain Life Sciences. With Intermountain, we will double our capacity to deliver buffers and liquid cell culture media and immediately ...
Irene Trovato on LinkedIn: Cytiva Acquires Intermountain Life …
WebCytiva acquires Intermountain Life Sciences. Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain ... Read article . 01-Apr-2024 Business . Introducing Cytiva. WebJul 1, 2024 · On June 29, 2024, Cytiva announced that it has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Through the acquisition, Cytiva will use Intermountain’s manufacturing site in Logan, Utah to rapidly boost its liquid cell culture production by millions of liters. diastasis recti in children nhs
グローバル ニトリルブタジエンゴムラテックス 市場規模 (2024 …
WebThe acquisition of Intermountain Life Sciences will double Cytiva’s capacity for buffers and liquid cell culture media at its manufacturing site in Logan, Utah. On June 29, 2024, Cytiva announced that it has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. WebJul 2, 2024 · Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain’s manufacturing site in Utah to rapidly boost its liquid cell culture production by millions of liters. Hiring is ongoing to rapidly increase output. WebJul 7, 2024 · Cytiva will use Intermountain’s manufacturing site in Utah to rapidly boost its liquid cell culture production by millions of liters. Hiring is ongoing to rapidly increase output. Olivier Loeillot, Vice President, Cytiva, says: “The demand for buffers and cell culture media has grown substantially in recent years thanks to their use in gene ... diastasis recti infants